ag 1295 and d-64406

ag 1295 has been researched along with d-64406 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baasner, S; Beckers, T; Böhmer, FD; Botzki, A; Dove, S; Hufsky, H; Kassack, MU; Mahboobi, S; Pongratz, H; Schächtele, C; Sellmer, A; Teller, S; Uberall, F; Uecker, A1
Böhmer, FD; Cénac, C; Dove, S; Eichhorn, E; Elz, S; Fischer, T; Heidel, F; Höcher, H; Hufsky, H; Mahboobi, S; Pongratz, H; Sellmer, A; Sicker, M; Stocking, C; Trümpler, A; Uecker, A1

Other Studies

2 other study(ies) available for ag 1295 and d-64406

ArticleYear
Bis(1H-2-indolyl)methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase.
    Journal of medicinal chemistry, 2002, Feb-28, Volume: 45, Issue:5

    Topics: Animals; Cell Division; DNA; Enzyme Inhibitors; Glycine; Humans; Indoles; Ketones; Kinetics; Models, Molecular; Molecular Structure; Phosphorylation; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor; Structure-Activity Relationship

2002
Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase.
    Journal of medicinal chemistry, 2006, Jun-01, Volume: 49, Issue:11

    Topics: Acute Disease; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; Humans; In Vitro Techniques; Indoles; Leukemia, Myeloid; Ligands; Mice; Models, Molecular; Phosphorylation; Pyrroles; Receptors, Platelet-Derived Growth Factor; Structure-Activity Relationship

2006